Filter
2180
Text search:
diagnostics
Featured
293
490
Language
Document type
882
446
399
149
125
75
28
22
19
14
9
5
2
1
1
Countries
133
88
57
51
44
34
34
33
32
31
30
30
28
26
26
25
24
24
23
22
22
19
19
18
16
16
16
14
14
13
13
13
12
12
12
11
11
11
9
9
8
8
8
8
7
7
6
6
6
6
6
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
693
220
107
99
62
40
24
1
Toolboxes
326
276
153
133
99
76
65
62
56
47
46
41
41
36
33
32
28
25
22
16
11
10
10
4
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section
...
Towards Malaria Elimination
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
National Tuberculosis and Leprosy Conrol Programme
Accessed November, 2017
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Policy statement.
The current document provides the background, justification and objectives for the revision of WHO policy on LF-LAM. It provides details on the index test (AlereLAM) being assessed. It also describes the process of evidence retrieval, quality assessment and grading; formulation of the recommendation
...
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.
Lignes directrices.
Collection Avis et Rapports.
A survival guide for clinicans.
3rd edition.
